Start exploring your own markets for free

🚀 Try for Free

Health Tech Forward Event 2024

Deep Dive running
Invite
Radar Tracking
Enhance your Space with Subspaces:By adding Subspaces, you help the AI to better understand and cater to your preferences.

Pending to review

Not sure yet

Interested

Not interested

Download list

Showing 276 results
Company
RelevanceNew!
Description
Subspaces
Tags
HQ Location
Founding Date
Employees
Total Funding Raised
Last Funding Event
Received on
United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.
Deep Dive
United States1996501 - 1000$648.00MIPO, $648.00M, June 17, 1999
Nov 26, 2024
Aquas is a Kensington, MD based private company whose line of business is Data processing/preparation
Deep Dive
United States199011 - 50NA
Nov 26, 2024
Developer of a legal and financial toolbox designed to collect and manage payments and donations. The company's toolbox helps in fiscal hosting and helps to manage budgets, pay expenses, receive donations, manage grants, and sell event tickets, enabling clients to collect money from members and donors and manage budgets easily.
Deep Dive
United Kingdom2017+10000$2.00MSeed, $2.00M, June 8, 2017
Nov 26, 2024
Sofia Angels Ventures is a € 13 million venture capital fund backed up by the European Investment Fund to co-invest alongside angels, family offices and other private investors and funds. We focus on technology startups at pre-seed & seed stage predominantly from Bulgaria, SEE & CEE countries but with a vision to operate around Europe and Globally. Sofia Angels Ventures is supported by InnovFin Equity, with the financial backing of the European Union under Horizon 2020 Financial Instruments and the European Fund for Strategic Investments (EFSI) set up under the Investment Plan for Europe. The purpose of EFSI is to help support financing and implementing productive investments in the European Union and to ensure increased access to financing.
Deep Dive
Bulgaria20201 - 10NA
Nov 26, 2024
Developer of a healthcare platform designed for the field of diagnostics, prognostics, and prediction of treatment response in oncology. The company's platform specializes in targeted RNA sequencing with the use of proprietary probes, and unique algorithms, which allow non-invasive detection of cervical abnormalities in women who are at risk of developing cervical cancer, these tests generate a histology-independent molecular diagnosis, predict a prognosis and produce a list of potentially successful precision medicines, enabling healthcare professionals to develop personalized treatment plans for cancer patients.
Deep Dive
Netherlands20201 - 10NA
Nov 26, 2024
Developer of a thermotherapy system designed for the head and neck region cancer treatment. The company's system offers a hyperthermia system that generates localized heating through an integrated system of microwave sources controlled by interactive software, enabling healthcare professionals to enhance regular therapy and balance treatment efficacy to improve the quality of life for cancer patients.
Deep Dive
Netherlands20151 - 10$14.06MVenture - Series Unknown, $7.16M, February 15, 2023
Nov 26, 2024
Developer of surgical patient risk management platform designed to enable proactive surgical care through personalized complication predictions. The company's AI-based cloud platform integrates with local EHR workflow and uses machine learning algorithms to aid clinical staff in predicting early warning of post-surgery infections and other major complications, enabling healthcare professionals to provide patients with prioritized health support and improved surgical outcomes at affordable costs.
Deep Dive
Netherlands20171 - 10$2.36MSeed, $100.00K, August 1, 2024
Nov 26, 2024
Developer of an eye test mobile application designed to self-examine their eye's refractive error at home using their smartphone. The company's technology uses an objective testing method for self-examination, enabling medical facilities to conduct eye screening tests with just a few clicks.
Deep Dive
Poland20211 - 10$681.88KGrant, June 17, 2024
Nov 26, 2024
Developer of healthcare application designed to help patients share information with doctors. The company's application interviews the patients so that they can communicate symptoms completely and accurately with the physician, enabling patients to be better prepared and helping doctors save time leading to better healthcare.
Deep Dive
United States20211 - 10NA
Nov 26, 2024
Developer of wireless headset designed to offer an (Artificial Intelligence) AI-powered neurofeedback platform that delivers personalized a real-time interventions to improve cognitive functions and behavior. The company's headset analyze brainwave data through (Artificial Intelligence) AI algorithms tailor neurofeedback sessions to each child's unique needs and ensures effective and individualized care by user-friendly platform, engaging children, and designed for use at home, enabling mental health care more accessible and less burdensome for families.
Deep Dive
United States201811 - 50Convertible Note, September 22, 2019
Nov 26, 2024